Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Erlangen-Nürnberg Medical School

About this trial

Aim of the study is to improve the diagnosis of food allergy and hypersensitivity. Intestinal homogenates will be used to determine total IgE, specific IgE, tryptase, histamine and inflammation parameters (IFNgamma, TNFalpha). These data will be correlated with serum values and disease status. In addition, organoids from duodenal tissue will be isolated and cultured in vitro and stimulated with the major food allergens. The gene and protein expression will be checked to identify relevant biomarkers.

Eligibility criteria

Qualifiers

informed consent

patients with suspected food allergy or hypersensitivity

healthy controls with indications for endoscopic diagnostics, e.g. tumour history within the family, exclusion of gastritis

Disqualifiers

pregnant person

Trial design

Treatments tested in this trial

  • biopsy sampling

Treatment groups

115 Participants
are divided into 2 treatment groups